Systemic antipsoriatic combination therapy with fumaric acid esters for plaque-type psoriasis: Report on 17 cases

Dermatology

Volumn 230, Issue 2, 2015, Pages 119-127

  Wilsmann Theis, Dagmar ^a   Frambach, Yvonne ^b   Philipp, Sandra ^c   Weyergraf, Ansgar J ^d   Jacobi, Arnd ^e   Mössner, Rotraut ^f   Gerdes, Sascha ^g  

^a UNIVERSITY OF BONN   (Germany)

^b UNIVERSITY OF LÜBECK   (Germany)

^c CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^d Fachklinik Bad Bentheim   (Germany)

^e UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

^f UNIVERSITY OF GÖTTINGEN   (Germany)

^g UNIVERSITY HOSPITAL SCHLESWIG HOLSTEIN   (Germany)

Author keywords

Acitretin; Combination therapy; Cyclosporine; Etanercept; Fumaric acid esters; Infliximab; Methotrexate; Psoriasis; Treatment

Indexed keywords

ANTIPSORIASIS AGENT; CYCLOSPORIN; ETANERCEPT; ETRETIN; FUMARIC ACID ESTER; INFLIXIMAB; LEFLUNOMIDE; METHOTREXATE; PREDNISOLONE; SALAZOSULFAPYRIDINE; UNCLASSIFIED DRUG; ANTIINFLAMMATORY AGENT; DERMATOLOGICAL AGENT; FUMARIC ACID DERIVATIVE; ISOXAZOLE DERIVATIVE; KERATOLYTIC AGENT;

ACTINIC KERATOSIS; ADULT; AGED; ALOPECIA; ARTICLE; BARRETT ESOPHAGUS; BASAL CELL CARCINOMA; BIOLOGICAL THERAPY; CLINICAL ARTICLE; DIARRHEA; DRUG WITHDRAWAL; FATIGUE; FEMALE; GASTROINTESTINAL SYMPTOM; GERMANY; HUMAN; HYPERTRANSAMINASEMIA; KIDNEY CARCINOMA; LYMPHOCYTOPENIA; MIDDLE AGED; PHOTOTHERAPY; PRIORITY JOURNAL; PROSTATITIS; PSORIASIS VULGARIS; PSORIATIC ARTHRITIS; PUVA; RETROSPECTIVE STUDY; SYSTEMIC THERAPY; THROMBOPHLEBITIS; TRICHOBACTERIOSIS; ULTRAVIOLET B RADIATION; UPPER RESPIRATORY TRACT INFECTION; URINARY TRACT INFECTION; VERY ELDERLY; CLINICAL TRIAL; DRUG COMBINATION; MALE; MULTICENTER STUDY; PATHOLOGY; PSORIASIS;

ACITRETIN; ADULT; AGED; ANTI-INFLAMMATORY AGENTS; CYCLOSPORINE; DERMATOLOGIC AGENTS; DRUG THERAPY, COMBINATION; ETANERCEPT; FEMALE; FUMARATES; GERMANY; HUMANS; INFLIXIMAB; ISOXAZOLES; KERATOLYTIC AGENTS; MALE; METHOTREXATE; MIDDLE AGED; PREDNISOLONE; PSORIASIS; RETROSPECTIVE STUDIES;

EID: 84924179614     PISSN: 10188665     EISSN: 14219832     Source Type: Journal    
DOI: 10.1159/000367890     Document Type: Article

References (22)

1. Parisi R, Symmons DP, Griffiths CE, Ashcroft DM: Global epidemiology of psoriasis: a systematic review of incidence and prevalence. J Invest Dermatol 2013; 133: 377-385.
2. Kanwar AJ, Yadav S, Dogra S: Psoriasis: what is new in nonbiologic systemic therapy in the era of biologics? Indian J Dermatol Venereol Leprol 2010; 76: 622-633.
3. Gerdes S, Mrowietz U: Comorbidities and psoriasis. Impact on clinical practice (in German). Hautarzt 2012; 63: 202-213.
4. Reich K: The concept of psoriasis as a systemic inflammation: implications for disease management. J Eur Acad Dermatol Venereol 2012; 26(suppl 2):3-11.
5. Glaser R, Gerdes S: Does the risk of cardiovascular complications decrease in psoriatic patients receiving systemic therapy? (in German). Hautarzt 2013; 64: 63-64.
6. Gisondi P, Del Giglio M, Cotena C, Girolomoni G: Combining etanercept and acitretin in the therapy of chronic plaque psoriasis: a 24-week, randomized, controlled, investigator-blinded pilot trial. Br J Dermatol 2008; 158: 1345-1349.
7. Heffernan MP: Combining traditional systemic and biologic therapies for psoriasis. Semin Cutan Med Surg 2010; 29: 67-69.
8. Lee EJ, Shin MK, Kim NI: A clinical trial of combination therapy with etanercept and low dose cyclosporine for the treatment of refractory psoriasis. Ann Dermatol 2010; 22: 138-142.
9. Smith EC, Riddle C, Menter MA, Lebwohl M: Combining systemic retinoids with biologic agents for moderate to severe psoriasis. Int J Dermatol 2008; 47: 514-518.
10. Gustafson CJ, Watkins C, Hix E, Feldman SR: Combination therapy in psoriasis: an evidence-based review. Am J Clin Dermatol 2013; 14: 9-25.
11. Philipp S, Wilsmann-Theis D, Weyergraf A, Rotterdam S, Frambach Y, Gerdes S, Mossner R: Combination of adalimumab with traditional systemic antipsoriatic drugs - a report of 39 cases. J Dtsch Dermatol Ges 2012; 10: 821-837.
12. Mohanan S, Ramassamy S, Chandrashekar L, Thappa DM: A retrospective analysis of combination methotrexate-cyclosporine therapy in moderate-severe psoriasis. J Dermatolog Treat 2014; 25: 50-53.
13. Heinecke GM, Luber AJ, Levitt JO, Lebwohl MG: Combination use of ustekinumab with other systemic therapies: a retrospective study in a tertiary referral center. J Drugs Dermatol 2013; 12: 1098-1102.
14. Nast A, Boehncke WH, Mrowietz U, Ockenfels HM, Philipp S, Reich K, Rosenbach T, Sammain A, Schlaeger M, Sebastian M, Sterry W, Streit V, Augustin M, Erdmann R, Klaus J, Koza J, Muller S, Orzechowski HD, Rosumeck S, Schmid-Ott G, Weberschock T, Rzany B: S3-guidelines for the treatment of psoriasis vulgaris: update 2011 (in German). J Dtsch Dermatol Ges 2011; 9(suppl 2):S1-S104.
15. Balasubramaniam P, Stevenson O, Berth-Jones J: Fumaric acid esters in severe psoriasis, including experience of use in combination with other systemic modalities. Br J Dermatol 2004; 150: 741-746.
16. Mrowietz U, Adamczyk A, Augustin M, Boehncke WH, Bonnekoh B, Gambichler T, Hengge U, Lippert U, Ludwig RJ, Luger T, Merk HF, Norgauer J, Philipp S, Reich K, Rocken M, Rostami-Yazdi M, Schon MP, Scola N, Sticherling M, Thaci D, Viehweg A, Wallbrecht K, Wozel G, Zouboulis CC, Neureither M: New information about fumaric acid esters (Fumaderm): results of a workshop of experts (in German). J Dtsch Dermatol Ges 2011; 9(suppl 4):1-13.
17. Rostami YM, Mrowietz U: Fumaric acid esters. Clin Dermatol 2008; 26: 522-526.
18. Dibbert S, Clement B, Skak-Nielsen T, Mrowietz U, Rostami-Yazdi M: Detection of fumarate-glutathione adducts in the portal vein blood of rats: evidence for rapid dimethylfumarate metabolism. Arch Dermatol Res 2013; 305: 447-451.
19. Reich K, Thaci D, Mrowietz U, Kamps A, Neureither M, Luger T: Efficacy and safety of fumaric acid esters in the long-term treatment of psoriasis - a retrospective study (FUTURE). J Dtsch Dermatol Ges 2009; 7: 603-611.
20. Mok CC, van der Kleij D, Wolbink GJ: Drug levels, anti-drug antibodies, and clinical efficacy of the anti-TNFα biologics in rheumatic diseases. Clin Rheumatol 2013; 32: 1429-1435.
21. Cozzani E, Burlando M, Parodi A: Detection of antibodies to anti-TNF agents in psoriatic patients: a preliminary study. G Ital Dermatol Venereol 2013; 148: 171-174.
22. Hsu L, Armstrong AW: Anti-drug antibodies in psoriasis: a critical evaluation of clinical significance and impact on treatment response. Expert Rev Clin Immunol 2013; 9: 949-958.